TrialThe Journal of dermatology2025

Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial.

Xingqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.